Bokf, Na Merck & Co., Inc. Transaction History

Bokf, Na

$5.65 Billion
Q3 2024

A detailed history of Bokf, Na transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bokf, Na holds 301,098 shares of MRK stock, worth $29.9 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

301,098

Previous 299,505 0.53%

Holding current value

$29.9 Million

Previous $37.1 Million 7.78%

% of portfolio

0.61%

Previous 0.67%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $177,061 - $205,449	1,593 Added 0.53%	301,098 $34.2 Million
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $475,763 - $510,965	-3,843 Reduced 1.27%	299,505 $37.1 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $8.93 Million - $10.4 Million	-78,828 Reduced 20.63%	303,348 $40 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $830,692 - $903,993	-8,292 Reduced 2.12%	382,176 $41.7 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $1.57 Million - $1.75 Million	-15,292 Reduced 3.77%	390,468 $40.2 Million
Q2 2023 Aug 21, 2023	SELL	$108.61 - $118.38 $1.39 Million - $1.51 Million	-12,767 Reduced 3.05%	405,760 $46.8 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $4.35 Million - $4.85 Million	-42,268 Reduced 9.17%	418,527 $44.5 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $2.37 Million - $3.03 Million	27,057 Added 6.24%	460,795 $51.1 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $3.66 Million - $4.11 Million	43,269 Added 11.08%	433,738 $37.4 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $5.7 Million - $6.46 Million	68,255 Added 21.18%	390,469 $35.6 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $746,200 - $836,442	-10,151 Reduced 3.05%	322,214 $26.4 Million
Q4 2021 Mar 11, 2022	SELL	$72.28 - $90.54 $1 Million - $1.25 Million	-13,855 Reduced 4.0%	332,365 $25.5 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $4.86 Million - $5.34 Million	67,754 Added 24.33%	346,220 $26 Million
Q1 2021 Apr 21, 2021	SELL	$68.86 - $81.11 $1.95 Million - $2.29 Million	-28,288 Reduced 9.22%	278,466 $21.5 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $948,584 - $1.05 Million	13,217 Added 4.5%	306,754 $25.1 Million
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $1.62 Million - $1.84 Million	-22,176 Reduced 7.02%	293,537 $24.3 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $2.47 Million - $2.81 Million	35,054 Added 12.49%	315,713 $24.4 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $4.2 Million - $5.81 Million	66,211 Added 30.88%	280,659 $21.6 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $1.53 Million - $1.73 Million	19,717 Added 10.13%	214,448 $19.5 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $1.27 Million - $1.38 Million	-16,647 Reduced 7.88%	194,731 $16.4 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $362,190 - $423,125	-5,186 Reduced 2.39%	211,378 $17.7 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $357,293 - $407,513	-5,135 Reduced 2.32%	216,564 $18 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $1.13 Million - $1.31 Million	17,273 Added 8.45%	221,699 $16.9 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $2.34 Million - $2.75 Million	-40,507 Reduced 16.54%	204,426 $14.5 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $1.11 Million - $1.3 Million	-21,750 Reduced 8.16%	244,933 $14.9 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $509,803 - $592,536	10,004 Added 3.9%	266,683 $14.5 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $101,949 - $121,739	1,975 Added 0.78%	256,679 $14.4 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $2.36 Million - $2.54 Million	40,284 Added 18.79%	254,704 $16.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	214,420	214,420 $13.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.

Account